S-alkylisothiouronium derivatives for treating abnormal uterine bleeding disorders
AssigneeBarkan-Farma S.R.L.
InventorsRefael Barkan, Victor Ghicavii
Life of this patent
Estimating the term…
Abstract
The present invention relates to methods for treating uterine hypercontractility disorders. In particular, the present invention relates to methods for treating abnormal uterine bleeding and dysmenorrhea comprising administering to women suffering from such disorders a pharmaceutical composition comprising an S-alkylisothiouronium derivative.
Claims20
A method for treating a uterine disorder comprising administering to a woman in need of such treatment a therapeutically effective amount of a pharmaceutical composition comprising as an active agent a compound of formula I:
- wherein
- R″ is a straight or branched alkyl, optionally substituted by halogen;
- and
- A″ (−) is an anion derived from a phosphorous containing acid, a phosphorous acid ester and a phosphorous acid amide, wherein the uterine disorder is selected from the group consisting of abnormal uterine bleeding and dysmenorrhea.
(canceled)
A vaginal or cervical device comprising a therapeutically effective amount of a pharmaceutical composition comprising as an active agent a compound of formula I:
- wherein
- R″ is a straight or branched alkyl, optionally substituted by halogen;
- and
- A″ (−) is an anion derived from a phosphorous containing acid, a phosphorous acid ester and a phosphorous acid amide.
(canceled)
Dependencies are inferred from the claim text.